Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_assertion type Assertion NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_head.
- NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_assertion description "[We further showed that inferior OS and DSS were most pronounced in patients whose lymphomas contained both TNFRSF14 mutations and 1p36 deletions after adjustment for the International Prognostic Index [hazard ratios of 3.65 (95% confidence interval, 1.35-9.878, P=0.011) and 3.19 (95% confidence interval, 1.06-9.57, P=0.039), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_provenance.
- NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_assertion evidence source_evidence_literature NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_provenance.
- NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_assertion SIO_000772 20884631 NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_provenance.
- NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_assertion wasDerivedFrom befree-20140225 NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_provenance.
- NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_assertion wasGeneratedBy ECO_0000203 NP836526.RAV14ZQoVN54fqY5Q87Zn1ddftxQ5Phesa8BlJlmCAUZ0130_provenance.